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Introduction
Diesters of 1,2-benzenedicarboxylic acid 
(phthalic acid), commonly referred to 
as phthalates, belong to a group of chemi-
cals with endocrine-disrupting proper-
ties, meaning that they can interfere with 
our normal hormonal balance, potentially 
resulting in adverse human health effects. A 
recent state-of-the-science report from the 
World Health Organization (WHO) provides 
new evidence for several human health risks 
from exposure to phthalates and other endo-
crine disruptors (EDCs) including reproduc-
tive health and sexual development (Bergman 
et al. 2013).
Phthalates are used as plasticizers in soft 
polyvinyl chloride (PVC) and found in a 
large number of commonly used consumer 
products including food, building mate-
rials, plastics, cosmetics, cleaning products, 
packages, and toys (Bornehag et al. 2005; 
Dodson et al. 2012; Rudel et al. 2011). 
Often, the fraction of phthalates in the 
plastics is as high as ≥ 30%. Because they are 
not covalently bound to the product matrix, 
phthalates can leach into the surrounding 
environment. As a result they are routinely 
found in indoor air (Bergh et al. 2011; Rudel 
and Perovich 2009) and dust (Abb et al. 
2009; Bornehag et al. 2004, 2005; Langer 
et al. 2010; Zhang et al. 2013), and food and 
water (Shi et al. 2012).
Phthalates are ubiquitous in the environ-
ment, and humans are exposed by multiple 
routes (oral, dermal, and inhalation), the 
pathway varying by phthalate. It has recently 
been shown, for example, that exposure 
to di(2-ethylhexyl) phthalate (DEHP) is 
primarily via food and for children also 
via mouthing of plastics, whereas exposure 
to diethyl phthalate (DEP) and benzyl-
butyl phthalate (BBzP) occurs primarily via 
dermal and inhalation pathways (Carlstedt 
et al. 2013; Koch et al. 2013; Wittassek 
et al. 2011). Robust biomonitoring data 
show phthalate metabolites in human fluids 
such as urine, both in children (Langer et al. 
2014) and adults (Wittassek et al. 2011), 
blood (Frederiksen et al. 2010; Wan et al. 
2013), and breast milk (Fromme et al. 2011). 
These compounds have also been found in 
amniotic fluid, suggesting that they cross the 
placental barrier and expose the fetus (Jensen 
et al. 2012).
One complication in studying phthalate 
exposure is that replacement of phthalates is 
continuously ongoing as risks are reported 
for older formulations. One example of this 
is the introduction of diisononyl phthalate 
(DiNP) and more recently diisononyl 
cyclohexane-1,2-dicarboxylate (DINCH) 
to replace DEHP in soft PVC [European 
Chemicals Agency (ECHA) 2013]. Recent 
biomonitoring data show that urinary levels of 
DEHP metabolites are decreasing while DiNP 
metabolites are increasing in European (Göen 
et al. 2011) and American populations (Silva 
et al. 2013).
Phthalates and reproductive health. The 
impact of endocrine-disrupting chemicals on 
male reproductive health has been a research 
focus for almost 20 years. During that time, 
multiple studies in laboratory animals (since 
1995) (Sharpe et al. 1995) and in humans 
(since 2005) (Swan et al. 2005) have demon-
strated the sensitivity of the developing male 
reproductive system to several phthalates. 
Phthalates may reduce the production of 
androgens by the testis and rodent studies 
have demonstrated that DEHP and dibutyl 
phthalate (DBP) disrupt androgen signaling 
when administered in the critical window for 
the development of the reproductive tract 
(MacLeod et al. 2010; van den Driesche et al. 
2011). In humans, similar findings suggest 
that phthalates (e.g., DEHP and DBP) 
may be related to male reproductive and 
 developmental abnormalities (ECHA 2013).
Anogenital distance and phthalate 
exposure. Anogenital distance (AGD)—the 
distance from the anus to the genitals—is 
a marker that has been used in animal 
studies to assess reproductive toxicity (U.S. 
Environmental Protection Agency 1996). 
AGD is a sexually dimorphic trait that 
develops in utero under androgen control and 
is 50–100% longer in males than females.
Numerous studies have shown that 
prenatal phthalate exposure (notably DEHP, 
DBP, BBzP) shortens male AGD in rodents 
(Foster 2005; van den Driesche et al. 2011). 
Only a few human studies have examined 
prenatal phthalate exposure and AGD. The 
first to examine this association in humans 
reported significant inverse relationships 
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Background: Phthalates are used as plasticizers in soft polyvinyl chloride (PVC) and in a large 
number of consumer products. Because of reported health risks, diisononyl phthalate (DiNP) has 
been introduced as a replacement for di(2-ethylhexyl) phthalate (DEHP) in soft PVC. This raises 
concerns because animal data suggest that DiNP may have antiandrogenic properties similar to 
those of DEHP. The anogenital distance (AGD)—the distance from the anus to the genitals—has 
been used to assess reproductive toxicity.
oBjective: The objective of this study was to examine the associations between prenatal phthalate 
exposure and AGD in Swedish infants.
Methods: AGD was measured in 196 boys at 21 months of age, and first-trimester urine was 
analyzed for 10 phthalate metabolites of DEP (diethyl phthalate), DBP (dibutyl phthalate), DEHP, 
BBzP (benzylbutyl phthalate), as well as DiNP and creatinine. Data on covariates were collected by 
questionnaires.
results: The most significant associations were found between the shorter of two AGD measures 
(anoscrotal distance; AGDas) and DiNP metabolites and strongest for oh-MMeOP [mono-
(4-methyl-7-hydroxyloctyl) phthalate] and oxo-MMeOP [mono-(2-ethyl-5-oxohexyl) phthalate]. 
However, the AGDas reduction was small (4%) in relation to more than an interquartile range 
increase in DiNP exposure.
conclusions: These findings call into question the safety of substituting DiNP for DEHP in 
soft PVC, particularly because a shorter male AGD has been shown to relate to male genital birth 
defects in children and impaired reproductive function in adult males and the fact that human levels 
of DiNP are increasing globally.
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between male AGD and DEP, DBP, BBzP, 
and mono-isobutyl phthalate (MiBP) metabo-
lites (Swan et al. 2005); and a later publication 
with a larger sample size and more powerful 
statistical methods found associations between 
male end points and metabolites of DEHP 
(Swan 2008). Recently a relationship between 
prenatal DEHP exposure and shorter AGD 
in male newborns was reported from Japan 
(Suzuki et al. 2012) and from Mexico 
(Bustamante-Montes et al. 2013). However, 
a study from Taiwan found a negative asso-
ciation between prenatal monobutyl phthalate 
(MBP) exposure and AGD in newborn girls 
but not in boys (Huang et al. 2009). To 
date no studies in humans have included 
 metabolites of DiNP.
Aim of the study. Animal data suggest 
that DiNP may have antiandrogenic proper-
ties similar to those of DEHP (Boberg et al. 
2011). This raises concerns because DiNP has 
been introduced to replace DEHP, and conse-
quently DiNP exposure is rapidly increasing 
in populations globally. Although several 
studies have examined phthalates and AGD in 
humans, none has included DiNP. Therefore, 
in the present study we examined the relation-
ship between first-trimester urinary metabolite 
concentrations of DEP, DBP, DEHP, and 
BBzP as well as DiNP in relation to anogenital 
distance in boys at 21 months of age.
Methods
Description of the SELMA study. The 
Swedish Environmental Longitudinal, 
Mother and child, Asthma and allergy 
(SELMA) study is a prospective birth cohort 
study in Sweden that includes > 2,000 
mother–child pairs followed from early preg-
nancy (Bornehag et al. 2012). The study aim 
was to investigate the impacts of early-life 
exposure to endocrine-disrupting chemicals 
and other exposures, for multiple outcomes 
of growth, development, and chronic diseases.
The SELMA cohort was established by 
recruiting women in the 10th week of preg-
nancy in the county of Värmland, Sweden, 
between September 2007 and March 2010. 
Of 8,394 reported pregnant women, 6,658 
were invited to participate in the study. 
Among the invited women, 2,582 agreed to 
participate, corresponding to a participating 
rate of 39%. Of the 4,076 nonparticipants, 
2,091 women were invited to complete 
a nonrespondent questionnaire for us to 
examine possible selection bias. We found a 
self-selection bias in the established cohort 
when compared with the nonparticipant 
group—participating families smoked less 
(14% vs. 19%), had more frequent asthma 
and allergy symptoms in the family (58% 
vs. 38%), had higher education (university 
level) among the mothers (51% vs. 36%), and 
more often lived in single-family houses (67% 
vs. 60%). However, there was no obvious 
reason that this selection bias would have an 
impact on identification of environmental 
risk factors for health effects. Detailed recruit-
ment procedures, selection criteria, and data 
relating to selection bias have been reported 
and discussed elsewhere (Bornehag et al. 
2012). Biological samples (blood and urine) 
have been collected from the 2,582 pregnant 
women and their children. Information 
related to lifestyles, socioeconomic status, 
living conditions, diet, and medical history 
has been collected using annual  questionnaires 
(Bornehag et al. 2012).
Measurements of AGD in baby boys. 
Boys born between 1 September 2009 and 
20 November 2010 (i.e., those who were 
< 18 months of age in the SELMA study) 
(n = 325) and their parents were invited 
to participate in the study; of these, 228 
participated (70%). Of these we were able to 
measure AGD in 225 boys, and of these, 196 
children are included in the present analyses. 
Mean age of the 196 boys was 20.8 months. 
AGD was measured by two nurses (one 
pediatric staff nurse and one midwife) from 
the County Council of Värmland who 
were trained by research staff from The 
Infant Development and the Environment 
Study (TIDES) (Barret et al. 2014). The 
nurses had no knowledge of the mother’s 
phthalate concentrations. All AGD measure-
ments were made in the baby’s home or at a 
 pediatric clinic.
We obtained two measurements of AGD 
using measurement methods that have been 
described elsewhere (Sathyanarayana et al. 
2010). Briefly, the longer AGD measurement 
(AGDap) was measured from the center of 
the anus to the anterior base of the penis, and 
the shorter (AGDas) from the center of the 
anus to the posterior base of the scrotum. The 
infant was placed on his back on a flat surface 
with his hips relaxed outward and pulled back 
towards his shoulders by his mother or an 
assistant. The examiner stood in front of the 
infant and made three measurements of both 
long and short AGD with a dial caliper; the 
coefficient of variation (CV) was calculated 
for each AGD measure. Only one measure-
ment was made for 12 boys regarding AGDas 
and for 24 boys regarding AGDap.
Phthalate metabolites in first-trimester 
urine. Of the 2,582 pregnant women partici-
pating in the SELMA study, a first morning 
urine sample was obtained from 2,356 women 
(91%) during weeks 9–11 of the pregnancy. 
The urine samples were stored frozen at 
–20°C. These samples were analyzed for the 
10 phthalate metabolites listed in Table 1. 
Briefly, 0.2 mL of urine were added with 
0.1 mL of ammonium acetate (pH 6.5) and 
0.01 mL glucoronidase (Escherichia coli) and 
thereafter incubated at 37°C for 30 min. 
Then we added 0.05 mL of a 50:50 (vol:vol) 
water and acetonitrile solution of labeled 
(3H or 13C) internal standards of all analyzed 
compounds. A C18 column (2.1 mm 
i.d. × 50 mm; Genesis Lightn; Grace, 
Deerfield, IL, USA) was used before the 
injector to reduce the interference of contami-
nants during the mobile phase. The phthalate 
metabolites in the samples were separated on 
a C18 column (1.5 μm, 2.0 mm i.d. × 30 mm 
VisionHT; Grace). The mobile phases were 
water and acetonitrile with 0.08% formic acid. 
The samples were analyzed on a Shimadzu 
UFLC system (Shimadzu Corporation, 
Kyoto, Japan) coupled to a QTRAP5500 
triple quadrupole linear ion trap mass spec-
trometer equipped with a TurboIon Spray 
source (AB Sciex, Foster City, CA, USA). The 
samples were analyzed in triplicate, and the 
Table 1. Analyzed phthalate metabolites in the urine of 196 pregnant women, their parent compounds including CAS (Chemical Abstracts Service) number, and 
limit of detection (LOD). 
Parent compound Metabolite
LOD (ng/mL)Diester name (acronym) CAS no. Monoester name Acronym CAS no.
Diethyl phthalate (DEP) 84-66-2 Mono-ethyl phthalate MEP 2306-33-4 0.01
Dibutyl phthalate (DBP) 84-74-2 Mono-n-butyl phthalate MnBP 131-70-4 0.10
Butylbenzyl phthalate (BBzP) 85-68-7 Mono-benzyl phthalate MBzP 2528-16-7 0.04
Di(2-ethylhexyl) phthalate (DEHP) 117-81-7 Mono-(2-ethylhexyl) phthalate MEHP 4376-20-9 0.10
Mono-(2-ethyl-5-hydroxylhexyl) phthalate oh-MEHP 40321-99-1 0.02
Mono-(2-ethyl-5-oxohexyl) phthalate oxo-MEHP 40321-98-0 0.03
Mono-(2-ethyl-5-carboxypentyl) phthalate cx-MEPP 40809-41-4 0.02
Diisononyl phthalate (DiNP) 68515-48-0 Mono-(4-methyl-7-hydroxyloctyl) phthalate oh-MMeOP 936021-98-6 0.02
Mono-(4-methyl-7-oxo octyl) phthalate oxo-MMeOP 936022-00-3 0.01
Mono-(4-methyl-7-carboxyheptyl) phthalate cx-MMeHP 936022-02-5 0.02
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mean of the two closest were reported. All 
samples were analyzed in a randomized order. 
For quality control of the analyses, chemical 
blanks and two different in-house prepared 
quality control samples were analyzed in all 
sample batches. The limit of detection (LOD) 
was defined as the concentration corre-
sponding to a peak area ratio of three times 
the standard deviation of the chemical blanks, 
and is shown in Table 1. The laboratory at 
Lund University is a reference laboratory for 
analyses of urinary phthalate metabolites in a 
European biomonitoring project [Consortium 
to Perform Human Biomonitoring on a 
European Scale (COPHES); http://www.
eu-hbm.info/cophes]. The creatinine concen-
trations were analyzed according to an enzy-
matic method described by Mazzachi et al. 
(2000). We calculated the sum of DEHP and 
DiNP metabolites by summing the metabolite 
concentrations on a molar basis.
Statistical analyses. Urinary levels of 
phthalate metabolites were log-transformed 
to normalize distributions and geometric 
means (GMs) with 95% confidence interval 
(CIs). Associations between log-transformed 
phthalate metabolite concentrations and 
AGD were estimated using a general linear 
model, and we present the beta coefficients 
with 95% CI. We also categorized covariate-
adjusted AGD (AGDas and AGDap) 
into “short” (< 25th percentile), “medium” 
(25th–75th percentile), and “long” (≥ 75th 
percentile) as a reference. We then used logistic 
regression models to estimate the odds ratio 
(OR) of having a boy with a short (adjusted) 
AGD compared with a long AGD as a 
function of log-transformed concentrations 
of phthalate metabolites in prenatal urine. 
Finally we examined the ORs for having a 
short AGD compared with a long AGD as 
a function of quartiles of phthalate metabo-
lite concentration in the pregnant women’s 
urine, with the lowest quartile as a reference. 
Therefore, using these models we examined the 
relation between prenatal phthalate exposure 
and AGD in three ways: a) both AGD and 
phthalate metabolite concentrations modeled 
as continuous variables; b) categorical AGDs 
vs. continuous phthalate metabolite concentra-
tions; and c) both AGD and phthalate metabo-
lite concentrations modeled as categorical 
variables (Figure 1).
The literature indicates that both age 
and body size can influence measures of 
AGD. Thus, we controlled for body size by 
using weight-for-age percentiles by the use 
of WHO standards (WHO 2009). Weight-
for-age percentiles are correlated with age, 
but much less correlated than weight and 
age (Swan 2008). Finally, in addition to 
weight-for-age, all models were adjusted for 
the boy’s age at examination (months), gesta-
tional week of urine sampling, and urinary 
creatinine concentration. A p-value < 0.05 
was considered statistically significant.
Ethical approval. The research ethics 
committee at Uppsala University, Sweden, 
approved the study, and informed consent 
was obtained from all participating adults.
Results
Study population. The study population for 
this analysis was quite similar to the entire 
SELMA study population. The 196 families 
included in the final analysis were somewhat 
better educated, smoked less, and were more 
likely to live in a single-family house and in a 
rural setting (Table 2).
AGD. AGD was measured on 225 boys 
(19–21 months of age) between June 2011 
and August 2012, and prenatal phthalates 
metabolites were available for 199 of them. 
Of these, one child was excluded due to 
an error in weight measurements and two 
children were excluded due to a CV for the 
AGD measurements > 10%, resulting in 
a study population of 196 children. These 
196 boys had a mean age of 20.8 months 
and a mean weight of 12.6 kg. In addition, 
AGDap was not measured on four of these 
boys, so for those analyses n = 192 (Table 3).
The median AGDas was 40.7 mm [inter-
quartile range (IQR) = 37.8–45.0 mm] while 
the median AGDap was 82.6 mm (IQR = 
78.0–87.4 mm). The mean CV was 2.3% for 
AGDas and 1.6% for AGDap (Table 3).
Phthalate metabolites. Ten phthalate 
metabolites and creatinine were measured in 
urine collected during weeks 9–11. The GM 
and 95% CI for the concentration of the 
10 metabolites as well as the sum of DEHP 
and DiNP metabolites are presented in 
Table 4. All phthalate metabolites were identi-
fied above LOD in all urine samples (Table 1). 
The distribution of the metabolite concen-
trations in the AGD study population was 
comparable with the distribution in the entire 
SELMA cohort (n = 2,356) (data not shown). 
Table 4 also provides unpublished data 
reflecting urinary levels of phthalate metabo-
lites in pregnant women of boys and girls from 
the Study for Future Families (SFF), whereas 
published data reflect boys only (Swan 2008; 
Figure 1. Adjusted odds ratio (OR) for having a short AGD (in the 1st quartile) compared with a long AGD 
(4th quartile) as a function of quartile of phthalate metabolite concentration in the pregnant women’s 
urine: (A) AGDas; (B) AGDap. ref, reference (1st quartile). Adjusted for age (months), gestational week of 
urine sampling, weight-for-age percentile, and creatinine. 
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Swan et al. 2005), as well as from the U.S. 
National Health and Nutrition Examination 
Survey (NHANES) study where data are 
from women of childbearing age [Centers for 
Disease Control and Prevention (CDC) 2014].
AGD in relation to phthalate exposure. 
Most of the phthalate metabolites were nega-
tively associated with AGD both before and 
after adjustment for covariates in multiple 
linear regression models; however, most of 
the associations did not reach significance. 
Strongest and most significant inverse asso-
ciations were found between AGDas and 
DiNP metabolites and most strongly for 
oh-MMeOP [mono-(4-methyl-7-hydroxyl-
octyl) phthalate] and oxo-MMeOP [mono-
(2-ethyl-5-oxohexyl) phthalate] and the sum 
of DiNP metabolites (Table 5).
These associations were also seen when 
AGD was stratified and phthalate concentra-
tions were compared by adjusted AGD quartile 
(Table 6). The ORs for having an AGDas in 
the 2nd–3rd quartile when compared with 
the 4th quartile as a function of (log-trans-
formed) DiNP metabolite concentrations 
were in the range of 1.1–1.2 but nonsignifi-
cant, whereas the ORs for having an AGDas 
in the 1st quartile when compared with the 
4th quartile was in the range of 2.6–3.1 and 
significant. We also saw weaker inverse associa-
tions between AGDap and DINP metabolites, 
which did not reach statistical significance. 
Associations between prenatal DEHP metabo-
lite exposure and shorter AGDas were also 
seen, though these associations did not reach 
statistical significance.
Finally, the odds of having a short AGDas 
(in the 1st quartile) when compared with a 
long AGDas (4th quartile) as a function of 
quartile of phthalate metabolite concentra-
tion showed a linear dose–response relation-
ship for prenatal DiNP metabolite exposure 
(Figure 1A). Similar but somewhat weaker 
associations were seen between AGDas and 
DEHP metabolites, as well as well as MBzP 
metabolites, whereas no associations were seen 
with MEP and MBP metabolites. No consis-
tent patterns were seen between AGDap and 
any of the phthalate metabolites (Figure 1B).
Discussion
Our finding that prenatal phthalate exposure 
is associated with shorter male AGD is consis-
tent with several earlier studies. However, 
Swan (2008) found associations between a 
shorter male AGD and prenatal exposure, 
particularly for DEHP metabolites, in 
mothers recruited in 2000–2003, whereas we 
saw a stronger association with DiNP metab-
olites. Mothers of the 196 boys included 
in the current analysis were pregnant in 
2009–2010. Phthalates in commerce changed 
Table 3. Measurements of the 196 boys including AGD and other characteristics.
Characteristic Mean ± SD
Percentile
25th 50th 75th
Age of child (months) 20.8 ± 1.6 19.7 20.7 21.8
Weight of child (kg) 12.6 ± 1.3 11.7 12.6 13.3
Gestational week for urine sampling 10.0 ± 2.3 9.0 10.0 11.0
AGD (mm)
AGDas 41.4 ± 5.98 37.8 40.7 45.0
AGDap (n = 192) 82.2 ± 6.94 78.0 82.6 87.4
CV (%)a
AGDas (n = 184) 2.28 1.03 1.59 2.91
AGDap (n = 168) 1.58 0.66 1.13 1.84
aFor 12 boys only one measurement was made for AGDas, and for 24 boys only one AGDap measurement was made.
Table 4. Distribution of urinary levels of phthalate metabolites (ng/mL) in 196 women in the present study and in two American studies, SFF and NHANES.
Phthalate Metabolite
Present study, 2008–2009  
(1st trimester)  
(n = 196)
SFF,a 2000–2003  
(2nd trimester)  
(n = 380)
NHANES,b 2005–2010 
(women 20–40 years) 
(n = 1,069)
GM (95% CI) 25th 50th 75th GM (95% CI) GM (95% CI)
DEP MEP 63.64 (54.35, 74.52) 30.67 60.56 134.12 149.00 (124.66, 178.10) 100.99 (89.28, 114.24)
DBP MBP 67.62 (60.02, 76.17) 43.13 66.03 111.78 15.04 (13.49, 16.77) 18.98 (17.34, 20.77)
BBzP MBzP 15.99 (13.50, 18.95) 7.85 15.08 35.58 9.97 (8.64, 11.50) 7.37 (6.63, 8.19)
DEHP MEHP 3.27 (2.87, 3.73) 1.91 3.30 5.86 3.23 (2.82, 3.70) 2.61 (2.31, 2.95)
oh-MEHP 14.42 (12.82, 16.22) 8.69 15.28 22.85 11.74 (10.28, 13.40) 18.30 (16.14, 20.73)
oxo-MEHP 9.68 (8.59, 10.91) 5.67 9.99 15.60 10.51 (9.26, 11.93) 11.67 (10.36, 13.14)
cx-MEPP 14.21 (12.63, 15.98) 8.00 14.53 22.50 19.97 (16.45, 24.24) 28.78 (25.71, 32.21)
ΣDEHPc 142.61 (126.99, 160.16) 84.56 148.13 220.71 118.33 (104.37, 134.17) —
DiNP oh-MMeOP 6.81 (5.60, 8.28) 2.83 6.27 14.23 — —
oxo-MMeOP 3.05 (2.56, 3.63) 1.33 2.75 6.22 — —
cx-MMeHP 10.81 (9.16, 12.75) 4.95 8.26 16.43 — —
ΣDiNPc 67.74 (57.00, 80.52) 28.28 55.91 124.92 — —
Creatinine (mmol/L) — 9.55 (8.94, 10.20) 7.00 9.60 13.10 — —
aUnpublished data from mothers of boys and girls; published data reflect boys only (Swan 2008; Swan et al. 2005). bBased on pooled 2005–2010 NHANES cycles, and women 
20–40 years of age (CDC 2014). cThe unit is nmol/L. 
Table 2. Characteristics of the study population of 196 boys and the families in the entire SELMA study 
(%).
Characteristic Present study (n = 196) SELMAa (n = 1,974)
Surrounding for the home
Urban 16.8 19.3
Suburban 47.1 47.9
Rural 36.1 32.9
Type of home
Single-family house 64.2 60.8
Row house 7.1 7.9
Apartment in multifamily house 26.4 29.5
Other 2.4 1.8
Education for the mother (highest)
Elementary school 2.8 3.9
High school (Gymnasium) 33.5 36.0
University 58.5 54.0
Other 5.2 6.0
Smoking in family
Any smoker in the family 16.0 18.4
aData from a questionnaire at week 10 of pregnancy when urine samples were collected from the pregnant women 
(n = 1,974).
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considerably between 2000 and 2010. Since 
then, DiNP has largely replaced DEHP in 
soft PVC applications such as flooring mate-
rials, and was measureable in 100% of the 
current mothers. Additionally, in the present 
study we observed associations primarily with 
the shorter AGD measure (AGDas) whereas 
in the SFF study associations were stronger 
for AGDap (Swan 2008)—a difference that 
may be attributable partly to subtle differ-
ences in measurement methods between the 
two studies, but is largely unexplained.
The inverse association between prenatal 
DiNP exposure and AGDas was significant, 
as expressed in Table 5, but the AGDas reduc-
tion was small in relation to the quite large 
increase in exposure. For example, more than 
an IQR increase in DiNP exposure (Table 4) 
was related to a 4% (1.69 mm) reduction in 
AGDas in the model (Table 5). About the 
same effect size has been found for DEHP 
exposure and AGD reduction in the SFF study 
(Swan 2008). However, such small relative 
differences have been associated with male 
genital birth defects and impaired reproductive 
function in adult males, as described below.
Our finding of an association between 
AGD and prenatal exposure to DiNP, and 
to a lesser extent to DEHP (nonsignificant), 
is not unexpected. DEHP is a known anti-
androgen (Foster 2005; Gray et al. 2000), 
and DiNP may be as well. Prenatal DiNP 
reduces testosterone production in Harlan 
rat pups (Hannas et al. 2011), although it is 
reported to be a less potent antiandrogen than 
DEHP. Furthermore, DiNP exposure in rats 
during gestation and perinatally increased the 
incidence of reproductive malformations in 
male offspring and caused alterations in fetal 
testicular testosterone production (Borch et al. 
2004; Gray et al. 2000). In addition, DiNP is 
an analog of DEHP—the reason for replacing 
DEHP with DiNP in soft PVC is that the two 
molecules have common chemical proper-
ties, which may also include antiandrogenic 
action. Our finding is also in line with some 
animal data. Prenatal exposure to DiNP has 
been found to reduce anogenital distance in 
male offspring rats in three studies; in Wistar 
rats (Boberg et al. 2011), in Wistar Imamichi 
rats (Lee et al. 2006), and in Sprague-Dawley 
rats (Ostby et al. 2001). In another study by 
Clewell et al. (2013b), AGD was reported 
to be reduced, but only on postnatal day 14 
and at the highest exposure level. Boberg 
et al. (2011) found similar dose-related 
effects of DiNP as those previously shown 
for DEHP and DBP. They stated that their 
finding supports the conclusion that DiNP 
has antiandrogenic properties and is therefore 
a reproductive toxicant. However, they also 
stated that DiNP appears to be less potent 
than DEHP and DBP. On the other hand, in 
three other studies no association was found 
between prenatal DiNP exposure and AGD in 
offspring rats (Clewell et al. 2013a; Gray et al. 
2000; Masutomi et al. 2004).
AGD measurements in SELMA boys were 
longer than those in SFF (Swan 2008; Swan 
et al. 2005). Median AGDap was 82.6 mm in 
SELMA and 70.2 mm in SFF; median AGDas 
was 40.7 mm in SELMA and 36.8 mm in SFF. 
These differences are at least partly attribut-
able to difference in age at examination; boys 
in SELMA averaged 20.8 months of age 
compared with 12.8 months in SFF. The other 
three studies reporting associations between 
prenatal phthalate exposure and AGD in 
offspring children are not comparable with ours 
because AGD in those studies was measured 
at birth (Bustamante-Montes et al. 2013; 
Sathyanarayana et al. 2010; Suzuki et al. 2012).
Prenatal urinary levels of phthalate 
metabolites in the 196 mothers were compa-
rable with those in the entire SELMA cohort, 
suggesting that there was no substantial selec-
tion bias (data not shown). The urinary levels 
of most phthalate metabolites are compa-
rable with those in SFF and NHANES, 
but there are differences. MBP metabolite 
levels are higher in Swedish pregnant 
women (SELMA), whereas MEP is higher in 
pregnant women in the United States (SFF, 
NHANES). MBzP (monobenzyl phthalate) 
metabolites levels are slightly higher in 
Sweden whereas the picture for DEHP 
metabolites is less clear, with both higher 
and lower levels in Swedish data (Table 4). 
There are no data for DiNP metabolites in 
SFF. However, based on more recent data 
for the DiNP metabolite cx-MMeHP 
Table 6. Association between AGD (short, medium, and long) and log-transformed concentrations of phthalate metabolites in prenatal urine calculated in an 
adjusteda logistic regression model [OR (95% CI)].
Phthalate Metabolite
AGDas AGDap
Short  
1st quartile
Medium  
2nd–3rd quartile
Long  
4th quartile (ref)
Short  
1st quartile
Medium  
2nd–3rd quartile
Long  
4th quartile (ref)
DBP MBP 1.84 (0.43, 7.91) 0.73 (0.21, 2.60) 1.0 1.83 (0.37, 9.02) 0.84 (0.23, 3.01) 1.0
DEP MEP 1.06 (0.47, 2.40) 0.84 (0.32, 2.16) 1.0 2.23 (0.80, 6.24) 1.11 (0.47, 2.62) 1.0
BBzP MBzP 1.92 (0.74, 5.00) 0.75 (0.33, 1.79) 1.0 1.49 (0.53, 4.17) 1.21 (0.52, 2.81) 1.0
DEHP MEHP 1.71 (0.52, 5.64) 1.04 (0.37, 2.93) 1.0 1.98 (0.51, 7.66) 4.01 (1.32, 12.20) 1.0
oh-MEHP 1.85 (0.50, 6.95) 0.89 (0.27, 2.92) 1.0 2.62 (0.58, 11.78) 3.05 (0.91, 10.16) 1.0
oxo-MEHP 1.47 (0.40, 5.37) 0.72 (0.22, 2.32) 1.0 2.23 (0.50, 9.87) 3.05 (0.93, 10.07) 1.0
cx-MEPP 1.76 (0.46, 6.70) 0.98 (0.30, 3.28) 1.0 1.76 (0.38, 8.27) 2.80 (0.82, 9.57) 1.0
ΣDEHP 1.82 (0.47, 7.06) 0.88 (0.26, 3.00) 1.0 2.44 (0.51, 11.72) 3.36 (0.96, 11.82) 1.0
DiNP oh-MMeOP 2.61 (1.24, 5.48) 1.08 (0.55, 2.09) 1.0 1.47 (0.67, 3.22) 1.17 (0.61, 2.24) 1.0
oxo-MMeOP 2.99 (1.28, 7.00) 1.17 (0.54, 2.53) 1.0 1.73 (0.70, 4.23) 1.28 (0.61, 2.70) 1.0
cx-MMeHP 3.11 (1.27, 7.66) 1.21 (0.52, 2.78) 1.0 1.77 (0.67, 4.65) 1.41 (0.62, 3.21) 1.0
ΣDiNP 3.02 (1.28, 7.09) 1.16 (0.52, 2.56) 1.0 1.69 (0.68, 4.20) 1.32 (0.61, 2.84) 1.0
ref, reference.
aAdjusted for age (months), gestational week for urine sampling, weight for age percentile, and creatinine.
Table 5. Association between AGD in boys and log-transformed concentrations of phthalate metabolites 
in prenatal urine from an adjusteda linear regression model.
Phthalate Metabolite
AGDas AGDap
β (95% CI) p-Value β (95% CI) p-Value
DBP MBP –1.41 (–4.39, 1.57) 0.351 –2.06 (–5.29, 1.18) 0.211
DEP MEP 0.63 (–1.29, 2.54) 0.518 –1.30 (–3.40, 0.81) 0.225
BBzP MBzP –1.66 (–3.56, 0.25) 0.088 –0.65 (–2.74, 1.44) 0.542
DEHP MEHP –1.28 (–3.74, 1.17) 0.304 –1.74 (–4.43, 0.95) 0.203
oh-MEHP –1.24 (–3.99, 1.51) 0.374 –1.50 (–4.50, 1.49) 0.324
oxo-MEHP –0.77 (–3.48, 1.94) 0.576 –1.25 (–4.19, 1.70) 0.406
cx-MEPP –0.89 (–3.69, 1.92) 0.534 –0.64 (–3.69, 2.40) 0.677
ΣDEHP –1.16 (–4.01, 1.68) 0.420 –1.39 (–4.49, 1.70) 0.375
DiNP oh-MMeOP –1.61 (–3.06, –0.16) 0.029 –1.23 (–2.83, 0.37) 0.131
oxo-MMeOP –1.82 (–3.47, –0.17) 0.031 –1.67 (–3.49, 0.15) 0.072
cx-MMeHP –1.51 (–3.26, 0.24) 0.091 –1.39 (–3.32, 0.53) 0.156
ΣDiNP –1.69 (–3.35, –0.02) 0.047 –1.46 (–3.29, 0.38) 0.119
aAdjusted for age (months), gestational week of urine sampling, weight-for-age percentile, and creatinine.
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[mono- (4 -methy l -7 - ca rboxyhep ty l ) 
phthalate], concentrations in pregnant 
women in Sweden and the United States were 
similar in 2008 (Silva et al. 2013).
The associations we observed between 
prenatal DiNP metabolites and a shorter AGD 
in baby boys raises concern for at least two 
reasons. First, anogenital distance has been 
shown to be associated with adverse health 
effects in humans. Three studies reported 
that male infants and boys with hypospadias 
or undescended testis had reduced AGD 
(Hsieh et al. 2012; Jain and Singal 2013; 
Thankamony et al. 2014). Moreover, a 
shorter AGD in adult men has been related 
to decreased fertility (Eisenberg et al. 2011), 
impaired semen quality (Mendiola et al. 
2011), and lower serum testosterone levels 
(Eisenberg et al. 2012). Shortened AGD has 
also been suggested as a biomarker of testicular 
dys genesis syndrome (Sharpe 2005). Second, 
the use of DiNP is increasing as it is used to 
replace DEHP in soft PVC, and consequently 
the human urinary levels of DiNP metabolites 
are rapidly increasing globally. The total global 
market for phthalates has been estimated by 
the ECHA to be about 6 million tons, with 
1.4 million tons in Europe, the Middle East, 
and Africa, 1.1 million tons in the Americas, 
and 3.5 million tons in Asia, and phthalates 
represent 84% of the global plasticizer market 
(ECHA 2013). Of the global market of plasti-
cizers, DiNP and DiDP (diisodecyl phthalate) 
were reported to represent about 32% (ECHA 
2013). Data from the American Chemistry 
Council (2012) indicate that the annual world 
production of DiNP was estimated to be about 
1.5 million tons in 2013, assuming a produc-
tion growth of 2.5% during the last years. 
Biomonitoring data from Europe and the 
United States also show that human urinary 
levels of DEHP metabolites are decreasing 
while DiNP metabolite concentrations are 
increasing (Göen et al. 2011; Silva et al. 2013).
Conclusions
The use of DiNP in soft PVC is increasing, 
and biomonitoring data show that human 
DiNP metabolite levels are rapidly increasing 
globally. Our data suggest that this substitute 
phthalate may not be safer than the chemical 
it is replacing. We find that DiNP is associ-
ated with a shorter AGD in boys at the age 
of 21 months, which is of concern because 
AGD has been related to male genital birth 
defects and impaired reproductive function in 
adult males.
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